Skip to main content
. Author manuscript; available in PMC: 2010 Apr 15.
Published in final edited form as: Cancer. 2009 Apr 15;115(8):1776–1783. doi: 10.1002/cncr.24192

Table 4.

Differences in rates of cognitive impairment between breast cancer survivors versus matched controls, controlling for age and overall intellectual ability

Chemo Controls z Radiation Controls z
Episodic memory
 CVLT immediate recall 12 (12%) 7 (7%) 1.07 6 (7%) 5 (6%) .19
 CVLT long delay free recall 21 (22%) 15 (15%) .65 16 (18%) 15 (17%) .41
 CVLT recognition 16 (16%) 5 (5%) 1.99* 10 (11%) 7 (8%) .98
 WMS-III Visual Reproduction immediate recall 8 (8%) 4 (4%) 1.36 10 (11%) 9 (10%) .67
 WMS-III Visual Reproduction delayed recall 8 (8%) 8 (8%) .30 7 (8%) 7 (8%) −.10
 WMS-III Visual Reproduction recognition 10 (10%) 7 (7%) .74 6 (7%) 6 (7%) .44
Attention
 WAIS-III Digit Span 5 (5%) 3 (3%) .47 4 (4%) 4 (4%) .65
 WAIS-III Spatial Span 5 (5%) 7 (7%) −.41 8 (9%) 9 (10%) −.03
 Trails A 8 (8%) 7 (7%) .53 13 (14%) 4 (4%) 2.16*
 2 & 7 Test speed 7 (7%) 6 (6%) .13 5 (6%) 6 (7%) −.32
 2 & 7 Test accuracy 11 (11%) 8 (8%) .79 10 (11%) 8 (9%) .76
Complex cognition
 WAIS-III Digit Symbol 9 (9%) 4 (4%) 1.49 8 (9%) 5 (6%) .81
 Trails B 8 (8%) 7 (7%) .38 11 (12%) 5 (6%) 1.95
 COWA total 8 (8%) 3 (3%) 1.76 4 (4%) 1 (1%) 1.14
Overall Impairment 33 (34%) 22 (23%) 1.71 27 (30%) 21 (23%) 1.67
*

p < .05,

**

p < .01